600436 片仔癀
已收盘 06-26 15:00:00
资讯
新帖
简况
每周股票复盘：片仔癀（600436）肠激安胶囊进入Ⅲ期临床
证券之星 · 01:57
每周股票复盘：片仔癀（600436）肠激安胶囊进入Ⅲ期临床
片仔癀（600436）披露2025年年度股东会决议公告，6月26日股价下跌2.51%
证券之星 · 06-26 22:19
片仔癀（600436）披露2025年年度股东会决议公告，6月26日股价下跌2.51%
片仔癀(600436.SH)：肠激安胶囊Ⅲ期临床试验完成首例试验参与者入组
智通财经 · 06-23
片仔癀(600436.SH)：肠激安胶囊Ⅲ期临床试验完成首例试验参与者入组
政策红利逐步兑现！中药板块价值重估进行时，片仔癀能否领跑？
证券之星 · 06-08
政策红利逐步兑现！中药板块价值重估进行时，片仔癀能否领跑？
每周股票复盘：片仔癀（600436）2025年营收90.01亿元
证券之星 · 06-07
每周股票复盘：片仔癀（600436）2025年营收90.01亿元
片仔癀：我司在售护龈牙膏系列产品丰富
证券之星 · 06-04
片仔癀：我司在售护龈牙膏系列产品丰富
每周股票复盘：片仔癀（600436）投资5000万参与再生医学基金
证券之星 · 05-31
每周股票复盘：片仔癀（600436）投资5000万参与再生医学基金
5月29日片仔癀涨6.10%，医药ETF易方达基金重仓该股
证券之星 · 05-29
5月29日片仔癀涨6.10%，医药ETF易方达基金重仓该股
片仔癀（600436）披露关于投资参与再生医学基金的进展公告，5月25日股价下跌0.1%
证券之星 · 05-25
片仔癀（600436）披露关于投资参与再生医学基金的进展公告，5月25日股价下跌0.1%
股市必读：片仔癀（600436）今年截至5月20日累计跌幅已超20%
证券之星 · 05-21
股市必读：片仔癀（600436）今年截至5月20日累计跌幅已超20%
片仔癀（600436）2026年一季报简析：净利润同比下降25.64%
证券之星 · 05-01
片仔癀（600436）2026年一季报简析：净利润同比下降25.64%
800亿“药中茅台”片仔癀，20年来营收首次下降
21世纪经济报道 · 04-30
800亿“药中茅台”片仔癀，20年来营收首次下降
片仔癀（600436）披露2025年度内部控制审计报告，4月30日股价上涨3.04%
证券之星 · 04-30
片仔癀（600436）披露2025年度内部控制审计报告，4月30日股价上涨3.04%
片仔癀增长神话终结？收入、利润双失速
华尔街见闻 · 04-30
片仔癀增长神话终结？收入、利润双失速
片仔癀最新公告：第一季度净利润同比下降25.64%
证券之星 · 04-29
片仔癀最新公告：第一季度净利润同比下降25.64%
片仔癀（600436）披露参与设立再生医学产业基金公告，3月30日股价下跌0.28%
证券之星 · 03-30
片仔癀（600436）披露参与设立再生医学产业基金公告，3月30日股价下跌0.28%
每周股票复盘：片仔癀（600436）子公司拟投5000万设生物医药基金
证券之星 · 03-29
每周股票复盘：片仔癀（600436）子公司拟投5000万设生物医药基金
片仔癀(600436.SH)：PZH2107Ⅱ期临床试验完成首例受试者入组
智通财经 · 02-10
片仔癀(600436.SH)：PZH2107Ⅱ期临床试验完成首例受试者入组
2月5日片仔癀发生1笔大宗交易 成交金额1680万元
证券之星 · 02-05
2月5日片仔癀发生1笔大宗交易 成交金额1680万元
1月27日增减持汇总：东方雨虹等8家公司拟减持 片仔癀增持（表）
新浪证券 · 01-27
1月27日增减持汇总：东方雨虹等8家公司拟减持 片仔癀增持（表）
加载更多
公司概况
公司名称：
漳州片仔癀药业股份有限公司
所属行业：
医药制造业
上市日期：
2003-06-16
主营业务：
漳州片仔癀药业股份有限公司的主营业务是医药制造业、医药流通业及化妆品业等。公司的主要产品是肝病用药、心脑血管用药。
发行价格：
8.55
{"stockData":{"symbol":"600436","market":"SH","secType":"STK","nameCN":"片仔癀","latestPrice":108,"timestamp":1782457201000,"preClose":110.78,"halted":0,"volume":3626660,"delay":0,"changeRate":-0.0251,"floatShares":603000000,"shares":603000000,"eps":3.1532,"marketStatus":"已收盘","change":-2.78,"latestTime":"06-26 15:00:00","open":110.95,"high":112.5,"low":108,"amount":398000000,"amplitude":0.0406,"askPrice":108,"askSize":237,"bidPrice":107.99,"bidSize":2,"shortable":0,"etf":0,"ttmEps":3.1532,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1782696600000},"marketStatusCode":5,"adr":0,"adjPreClose":110.78,"symbolType":"stock","openAndCloseTimeList":[[1782437400000,1782444600000],[1782450000000,1782457200000]],"highLimit":121.86,"lowLimit":99.7,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":603317210,"isCdr":false,"pbRate":4.28,"roa":"--","peRate":34.25092,"roe":"5.0%","epsLYR":3.58,"committee":-0.903704,"marketValue":65158000000,"turnoverRate":0.006,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-06-29。","floatMarketCap":65158000000},"requestUrl":"/m/hq/s/600436","defaultTab":"news","newsList":[{"id":"2646313825","title":"每周股票复盘：片仔癀（600436）肠激安胶囊进入Ⅲ期临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2646313825","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646313825?lang=zh_cn&edition=full","pubTime":"2026-06-28 01:57","pubTimestamp":1782583029,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘，片仔癀报收于108.0元，较上周的112.89元下跌4.33%。本周，片仔癀6月23日盘中最高价报115.98元。来自公司公告汇总：肠激安胶囊完成首例受试者入组，正式进入Ⅲ期临床试验阶段。交易信息汇总6月26日片仔癀现302.4万元大宗交易。泰和泰（北京）律师事务所对本次会议进行了见证并出具法律意见书，认为会议召集、召开程序、表决结果合法有效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062800000395.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0188","600436","BK0196","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646637023","title":"片仔癀（600436）披露2025年年度股东会决议公告，6月26日股价下跌2.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2646637023","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646637023?lang=zh_cn&edition=full","pubTime":"2026-06-26 22:19","pubTimestamp":1782483558,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘，片仔癀报收于108.0元，较前一交易日下跌2.51%，最新总市值为651.58亿元。该股当日开盘110.95元，最高112.5元，最低108.0元，成交额达3.98亿元，换手率为0.6%。近日，漳州片仔癀药业股份有限公司发布《2025年年度股东会决议公告》。公告显示，公司于2026年6月26日在漳州市芗城区姜园亭78号片仔癀温泉酒店召开2025年年度股东会，会议由董事长林志辉主持，采用现场与网络投票相结合方式举行。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062600045572.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","600436","BK0028","BK0196","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645887410","title":"片仔癀(600436.SH)：肠激安胶囊Ⅲ期临床试验完成首例试验参与者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2645887410","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645887410?lang=zh_cn&edition=full","pubTime":"2026-06-23 18:01","pubTimestamp":1782208887,"startTime":"0","endTime":"0","summary":"智通财经APP讯，片仔癀(600436.SH)发布公告，近日，公司研发的1.1类中药创新药肠激安胶囊顺利完成“肠激安胶囊治疗腹泻型肠易激综合征(肝气乘脾证)有效性和安全性的多中心、随机、双盲、安慰剂对照Ⅲ期临床试验”首例试验参与者入组工作，正式进入Ⅲ期临床试验。肠激安胶囊具有健脾疏肝、清热祛湿、止痛止泻的功效。肠激安胶囊Ⅲ期临床试验采用多中心、随机、双盲、安慰剂平行对照临床试验设计，以“治疗8周末腹泻(粪便性状)应答率”作为主要疗效指标，旨在确证肠激安胶囊治疗腹泻型肠易激综合征(肝气乘脾证)的有效性和安全性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1457570.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"片仔癀(600436.SH)：肠激安胶囊Ⅲ期临床试验完成首例试验参与者入组","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0188","600436","BK0196","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641310892","title":"政策红利逐步兑现！中药板块价值重估进行时，片仔癀能否领跑？","url":"https://stock-news.laohu8.com/highlight/detail?id=2641310892","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641310892?lang=zh_cn&edition=full","pubTime":"2026-06-08 10:39","pubTimestamp":1780886348,"startTime":"0","endTime":"0","summary":"中药板块价值重估进行时，片仔癀能否领跑？这份全产业链的重磅规划，为长期估值处于历史低位的中药板块，打开了明确的价值重估空间。这意味着，具备全产业链优势和创新能力的头部企业，将成为政策红利的最大受益者。作为中药行业的龙头企业，片仔癀的发展战略与政策导向高度契合。随着政策红利逐步释放与企业基本面改善，这为片仔癀的价值修复提供了底层支撑。#重新认识片仔癀##读懂片仔癀核心价值#本文来源：财经报道网","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://news.stockstar.com/IG2026060800006538.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","600436","BK0196","BK0028","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641794122","title":"每周股票复盘：片仔癀（600436）2025年营收90.01亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2641794122","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641794122?lang=zh_cn&edition=full","pubTime":"2026-06-07 01:43","pubTimestamp":1780767791,"startTime":"0","endTime":"0","summary":"截至2026年6月5日收盘，片仔癀报收于121.49元，较上周的128.41元下跌5.39%。本周，片仔癀6月2日盘中最高价报129.22元。来自公司公告汇总：片仔癀将于2026年6月26日召开2025年年度股东会，审议利润分配预案等六项议案。漳州片仔癀药业股份有限公司董事会提交2025年年度股东会会议材料，披露公司2025年实现合并营业收入约90.01亿元，归母净利润21.59亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060700000381.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600436"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640415908","title":"片仔癀：我司在售护龈牙膏系列产品丰富","url":"https://stock-news.laohu8.com/highlight/detail?id=2640415908","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640415908?lang=zh_cn&edition=full","pubTime":"2026-06-04 18:27","pubTimestamp":1780568866,"startTime":"0","endTime":"0","summary":"证券之星消息，片仔癀06月04日在投资者关系平台上答复投资者关心的问题。一群没用过片仔癀的年轻人评论这是智商税，不相信中医。我问片仔癀口腔护理官方旗舰店客服也只有日常护理的牙膏，没有专门治疗牙龈出血的牙膏）片仔癀回复：尊敬的投资者您好，感谢您的宝贵建议与推广，相关内容已转交产品研发板块。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060400032822.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0239","600436","BK0028","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639960165","title":"每周股票复盘：片仔癀（600436）投资5000万参与再生医学基金","url":"https://stock-news.laohu8.com/highlight/detail?id=2639960165","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639960165?lang=zh_cn&edition=full","pubTime":"2026-05-31 01:20","pubTimestamp":1780161623,"startTime":"0","endTime":"0","summary":"截至2026年5月29日收盘，片仔癀报收于128.41元，较上周的124.08元上涨3.49%。本周，片仔癀5月29日盘中最高价报129.71元。片仔癀当前最新总市值774.72亿元，在中药板块市值排名2/66，在两市A股市值排名266/5207。本周关注点公司公告汇总：片仔癀投资认缴5,000万元参与设立再生医学基金，出资比例为45.4545%。公司公告汇总漳州片仔癀药业股份有限公司的全资子公司片仔癀投资于2026年3月27日与其他机构签署合伙协议，共同设立漳州市再生医学产业投资基金合伙企业。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026053100000159.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","600436","BK0196","BK0028","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639364042","title":"5月29日片仔癀涨6.10%，医药ETF易方达基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2639364042","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639364042?lang=zh_cn&edition=full","pubTime":"2026-05-29 16:25","pubTimestamp":1780043115,"startTime":"0","endTime":"0","summary":"证券之星消息，5月29日片仔癀涨6.10%，收盘报128.41元，换手率1.58%，成交量9.51万手，成交额12.01亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共21家，其中持有数量最多的公募基金为易方达基金的医药ETF易方达。医药ETF易方达目前规模为172.15亿元，最新净值0.3354，较上一交易日下跌2.07%，近一年下跌8.59%。医药ETF易方达的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052900029794.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["512010","BK0028","600436","BK0188","BK0239","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638556785","title":"片仔癀（600436）披露关于投资参与再生医学基金的进展公告，5月25日股价下跌0.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638556785","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638556785?lang=zh_cn&edition=full","pubTime":"2026-05-25 22:15","pubTimestamp":1779718524,"startTime":"0","endTime":"0","summary":"截至2026年5月25日收盘，片仔癀报收于123.96元，较前一交易日下跌0.1%，最新总市值为747.87亿元。近日，漳州片仔癀药业股份有限公司发布《关于投资参与再生医学基金的进展公告》。公告显示，2026年3月27日，公司全资子公司片仔癀投资与多家机构签署合伙协议，共同设立漳州市再生医学产业投资基金合伙企业，基金认缴出资总额为11,000.00万元，片仔癀投资作为有限合伙人认缴出资5,000.00万元，出资比例为45.4545%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052500033986.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600436","BK0188","BK0239","BK0196","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637822611","title":"股市必读：片仔癀（600436）今年截至5月20日累计跌幅已超20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637822611","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637822611?lang=zh_cn&edition=full","pubTime":"2026-05-21 02:04","pubTimestamp":1779300255,"startTime":"0","endTime":"0","summary":"截至2026年5月20日收盘，片仔癀报收于127.5元，下跌0.77%，换手率0.51%，成交量3.06万手，成交额3.9亿元。交易信息汇总股价提醒5月20日片仔癀收盘报127.5元，跌0.77%，当日成交306.27万元。该股已连续7日下跌，当年累计跌幅21.28%。前10个交易日主力资金累计净流出5.03亿元，股价累计下跌7.61%；融资余额累计增加9501.21万元，融券余量累计增加3580股。过去90天内共有4家机构对其发布评级，其中买入评级2家，增持评级2家，机构目标均价为196.14元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052100002319.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0188","600436","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632667620","title":"片仔癀（600436）2026年一季报简析：净利润同比下降25.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632667620","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632667620?lang=zh_cn&edition=full","pubTime":"2026-05-01 06:09","pubTimestamp":1777586991,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期片仔癀发布2026年一季报。根据财报显示，片仔癀净利润同比下降25.64%。截至本报告期末，公司营业总收入27.41亿元，同比下降12.74%，归母净利润7.43亿元，同比下降25.64%。去年的净利率为23.81%，算上全部成本后，公司产品或服务的附加值高。持有片仔癀最多的基金为医药ETF易方达，目前规模为172.15亿元，最新净值0.3697，较上一交易日下跌0.88%，近一年上涨6.33%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050100004524.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600436"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631596296","title":"800亿“药中茅台”片仔癀，20年来营收首次下降","url":"https://stock-news.laohu8.com/highlight/detail?id=2631596296","media":"21世纪经济报道","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631596296?lang=zh_cn&edition=full","pubTime":"2026-04-30 22:51","pubTimestamp":1777560660,"startTime":"0","endTime":"0","summary":" 4月29日晚，“药中茅台”片仔癀交出了一份营收、净利双双下降的年度成绩单。 财报显示，2025年，公司实现营收90.01亿元，同比下降16.56%，为2003年上市以来首次下降；归母净利润21.59亿元，同比下降27.49%，为2010年以来首次下降；扣非归母净利润为20.00亿元，同比下降34.25%。 片仔癀指出，公司扣非归母净利润与2024年相比有较大变化，主要是因为本期医药制造业营业收入以及毛利率下降。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/wm/2026-04-30/doc-inhwhzrw6091317.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-04-30/doc-inhwhzrw6091317.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["600519","600436"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631681946","title":"片仔癀（600436）披露2025年度内部控制审计报告，4月30日股价上涨3.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631681946","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631681946?lang=zh_cn&edition=full","pubTime":"2026-04-30 17:21","pubTimestamp":1777540908,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，片仔癀报收于143.55元，较前一交易日上涨3.04%，最新总市值为866.06亿元。该股当日开盘139.6元，最高146.97元，最低139.6元，成交额达11.47亿元，换手率为1.32%。公司于2026年4月30日披露《漳州片仔癀药业股份有限公司2025年度内部控制审计报告》。公告显示，致同会计师事务所对漳州片仔癀药业股份有限公司2025年12月31日的财务报告内部控制有效性进行了审计。审计依据为《企业内部控制审计指引》及相关执业准则。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000055383.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0188","BK0239","600436","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631456681","title":"片仔癀增长神话终结？收入、利润双失速","url":"https://stock-news.laohu8.com/highlight/detail?id=2631456681","media":"华尔街见闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631456681?lang=zh_cn&edition=full","pubTime":"2026-04-30 17:01","pubTimestamp":1777539665,"startTime":"0","endTime":"0","summary":"10年来首次","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3771390","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["600436","BK0239","BK0188","BK0028","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631519100","title":"片仔癀最新公告：第一季度净利润同比下降25.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631519100","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631519100?lang=zh_cn&edition=full","pubTime":"2026-04-29 20:14","pubTimestamp":1777464855,"startTime":"0","endTime":"0","summary":"片仔癀(600436.SH)公告称，2026年第一季度实现营业收入27.41亿元，同比下降12.74%；归属于上市公司股东的净利润为7.43亿元，同比下降25.64%。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900061534.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600436"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623313223","title":"片仔癀（600436）披露参与设立再生医学产业基金公告，3月30日股价下跌0.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623313223","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623313223?lang=zh_cn&edition=full","pubTime":"2026-03-30 17:34","pubTimestamp":1774863260,"startTime":"0","endTime":"0","summary":"截至2026年3月30日收盘，片仔癀报收于152.5元，较前一交易日下跌0.28%，最新总市值为920.06亿元。该股当日开盘151.7元，最高152.93元，最低151.5元，成交额达1.56亿元，换手率为0.17%。近日，漳州片仔癀药业股份有限公司发布《关于参与设立私募基金对外投资的公告》。公告显示，公司全资子公司漳州片仔癀投资管理有限公司参与设立漳州市再生医学产业投资基金合伙企业，认缴出资5,000.00万元，出资比例为45.4545%，资金来源为自有资金。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026033000024172.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","600436","BK0196","BK0028","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623333302","title":"每周股票复盘：片仔癀（600436）子公司拟投5000万设生物医药基金","url":"https://stock-news.laohu8.com/highlight/detail?id=2623333302","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623333302?lang=zh_cn&edition=full","pubTime":"2026-03-29 04:59","pubTimestamp":1774731547,"startTime":"0","endTime":"0","summary":"截至2026年3月27日收盘，片仔癀报收于152.93元，较上周的156.28元下跌2.14%。本周，片仔癀3月23日盘中最高价报155.27元。片仔癀当前最新总市值922.65亿元，在中药板块市值排名2/67，在两市A股市值排名203/5191。本周关注点公司公告汇总：片仔癀子公司拟出资5,000万元参与设立生物医药产业基金。该基金认缴总额为11,000.00万元，主要投资于生物医药领域。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032900001293.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["160635","BK0028","BK0239","BK0188","600436","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610610047","title":"片仔癀(600436.SH)：PZH2107Ⅱ期临床试验完成首例受试者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2610610047","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610610047?lang=zh_cn&edition=full","pubTime":"2026-02-10 17:07","pubTimestamp":1770714453,"startTime":"0","endTime":"0","summary":"智通财经APP讯，片仔癀 发布公告，近日，公司与上海璃道医药科技有限公司合作研发项目—PZH2107，已完成“LDS片治疗纤维肌痛的随机、双盲、安慰剂平行对照、多中心、Ⅱ期临床试验”的首例受试者入组，正式进入Ⅱ期临床试验。该临床试验方案已获得牵头单位中国医学科学院北京协和医院药物临床试验伦理委员会审查批准，并于2026年2月8日完成首例受试者入组。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1403699.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"片仔癀(600436.SH)：PZH2107Ⅱ期临床试验完成首例受试者入组","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0196","BK0188","600436","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609783823","title":"2月5日片仔癀发生1笔大宗交易 成交金额1680万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2609783823","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609783823?lang=zh_cn&edition=full","pubTime":"2026-02-05 17:34","pubTimestamp":1770284056,"startTime":"0","endTime":"0","summary":"证券之星消息，2月5日片仔癀发生大宗交易，交易数据如下：大宗交易成交价格160元，相对当日收盘价折价6.13%，成交10.5万股，成交金额1680万元，买方营业部为东方证券股份有限公司上海徐汇广元西路证券营业部，卖方营业部为东方证券股份有限公司上海徐汇广元西路证券营业部。近三个月该股共发生1笔大宗交易，合计成交1050.0手，折价成交1笔。截至2026年2月5日收盘，片仔癀报收于170.44元，上涨4.0%，换手率1.44%，成交量8.67万手，成交额14.64亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020500028491.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600436","BK0188","BK0028","BK0239","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606825597","title":"1月27日增减持汇总：东方雨虹等8家公司拟减持 片仔癀增持（表）","url":"https://stock-news.laohu8.com/highlight/detail?id=2606825597","media":"新浪证券","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606825597?lang=zh_cn&edition=full","pubTime":"2026-01-27 21:15","pubTimestamp":1769519700,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 据统计，1月27日，盘后片仔癀披露增持情况。达意隆、东方雨虹、视觉中国、恒邦股份、百达精工、傲农生物（维权）、复洁科技、索菱股份等8家上市公司披露拟减持情况。\n\n\n新浪声明：此消息系转载自新浪合作媒体，新浪网登载此文出于传递更多信息之目的，并不意味着赞同其观点或证实其描述。文章内容仅供参考，不构成投资建议。投资者据此操作，风险自担。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/marketresearch/2026-01-27/doc-inhiucrr9650399.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0187","LU0516422366.SGD","LU0516423091.SGD","002271","600436","LU2580892789.USD","LU2580892862.HKD","LU0516422952.EUR","BK0196","BK0039","LU0516423174.USD","LU0979878070.USD","LU1242518857.USD","BK0197","BK0028","LU1242518931.SGD","SGXZ81163826.USD","LU1688375341.USD","LU0516422440.USD","BK0239","BK0188","SGXZ49509284.SGD","BK0235","BK0201"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1782644504776,"stockEarnings":[{"period":"1week","weight":-0.0433},{"period":"1month","weight":-0.1296},{"period":"3month","weight":-0.2938},{"period":"6month","weight":-0.3655},{"period":"1year","weight":-0.4535},{"period":"ytd","weight":-0.3601}],"compareEarnings":[{"period":"1week","weight":-0.0155},{"period":"1month","weight":-0.0162},{"period":"3month","weight":0.029},{"period":"6month","weight":0.016},{"period":"1year","weight":0.1678},{"period":"ytd","weight":0.0147}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"漳州片仔癀药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"129937人(较上一季度增加0.54%)","perCapita":"4643股","listingDate":"2003-06-16","address":"福建省漳州市芗城区琥珀路1号","registeredCapital":"60331万元","survey":" 漳州片仔癀药业股份有限公司的主营业务是医药制造业、医药流通业及化妆品业等。公司的主要产品是肝病用药、心脑血管用药。","listedPrice":8.55},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"片仔癀(600436)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供片仔癀(600436)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"片仔癀,600436,片仔癀股票,片仔癀股票老虎,片仔癀股票老虎国际,片仔癀行情,片仔癀股票行情,片仔癀股价,片仔癀股市,片仔癀股票价格,片仔癀股票交易,片仔癀股票购买,片仔癀股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"片仔癀(600436)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供片仔癀(600436)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}